Robyn Rapaport

Insider Reports History

Entity
Individual
Location
Cero Therapeutics Holdings, Inc., 2201 Broadway, Suite 705, Oakland, CA
Signature
/s/ Charles Carter, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robyn Rapaport:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PHOENIX BIOTECH ACQUISITION CORP. Director Common Stock 50K $5K $0.10 Feb 14, 2024 Direct
CERO THERAPEUTICS HOLDINGS, INC. Director Stock Option (Right to Buy) 113K Mar 25, 2024 Direct

Insider Reports Filed by Robyn Rapaport

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CERO CERO THERAPEUTICS HOLDINGS, INC. Mar 25, 2024 1 $0 4 Mar 27, 2024 Director
CERO PHOENIX BIOTECH ACQUISITION CORP. Feb 14, 2024 0 $0 3 Feb 16, 2024 Director